| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| PALISADE BIO, INC. | Chief Medical Officer | Common Stock, par value $0.01 | 3.85K | $18.3K | $4.76 | May 28, 2024 | Direct |
| PALISADE BIO, INC. | Chief Medical Officer | Restricted Stock Units | 24K | $0 | $4.76 | Feb 11, 2025 | Direct |
| PALISADE BIO, INC. | Chief Medical Officer | Stock Option (Right to Buy) | 29K | Feb 11, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| PALI | PALISADE BIO, INC. | Feb 11, 2025 | 2 | $0 | 4 | Feb 13, 2025 | Chief Medical Officer |
| PALI | PALISADE BIO, INC. | May 28, 2024 | 6 | -$6.05K | 4 | May 30, 2024 | Chief Medical Officer |
| PALI | PALISADE BIO, INC. | May 6, 2024 | 6 | -$1.16K | 4 | May 8, 2024 | CEO, CFO, Director |
| PALI | PALISADE BIO, INC. | Nov 21, 2023 | 2 | $0 | 4 | Nov 24, 2023 | Chief Medical Officer |
| PALI | PALISADE BIO, INC. | Nov 6, 2023 | 3 | -$878 | 4 | Nov 8, 2023 | Chief Medical Officer |
| PALI | PALISADE BIO, INC. | Sep 5, 2023 | 0 | $0 | 3 | Sep 13, 2023 | Chief Medical Officer |
| PALI | PALISADE BIO, INC. | Feb 6, 2023 | 5 | -$939 | 4 | Feb 8, 2024 | Chief Medical Officer |